Birch Triterpenes

Brand names: Filsuvez · Active ingredient: Birch Triterpenes

In short: FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

Forms & strengthsTopical gel: 10% birch triterpenes w/w in a colorless to slightly yellowish, opalescent, non-aqueous gel supplied in 25 mL sterile tubes.
LabelChiesi USA, Inc.
Label updatedJul 28, 2026

What is Birch Triterpenes used for?

FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

Birch Triterpenes dosage

Wash hands before and after applying FILSUVEZ or wear gloves for application.

Apply a 1 mm layer of FILSUVEZ to the affected wound surface only. Do not rub in the gel. Cover the wound with a sterile non-adhesive wound dressing. Alternatively, apply FILSUVEZ directly to the dressing so that the topical gel is in direct contact with the wound.

Apply FILSUVEZ to cleansed wounds with wound dressing changes until the wound is healed.

If a FILSUVEZ-treated wound becomes infected, discontinue treatment to that wound until the infection has resolved.

Each tube of FILSUVEZ is for one-time use only. Once the tube is opened, use the product immediately. Discard the tube after use in household trash or through a drug take back site, if available.

Avoid contact of FILSUVEZ with eyes and mucous membranes (e.g., mouth, vagina, anus). In case of accidental contact, irrigate the area with water.

FILSUVEZ is for topical use only. Not for use on mucous membranes (oral, intravaginal, or intra-anal). Not for ophthalmic use.

How to take Birch Triterpenes — instructions & advice from the label

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Administration Instructions

Advise patients (and/or their caregivers or guardians) of the following :

Wash hands before and after applying FILSUVEZ or wear gloves for application.

Apply a 1 mm layer of FILSUVEZ to the affected wound surface. Do not rub in the gel. Cover the wound with a sterile non-adhesive wound dressing. Alternatively, apply a generous layer of FILSUVEZ directly to the dressing so that the gel is in direct contact with the wound.

Apply FILSUVEZ to cleansed wounds at dressing changes until the wound is healed.

FILSUVEZ is for topical use only. FILSUVEZ is not for ophthalmic use and should not be applied to mucous membranes. In case of accidental contact, irrigate eyes with water.

The sterile tube of topical gel is for one-time use only. Once the tube is opened, use the product immediately. Discard the tube after use, even if there is some topical gel left.

Hypersensitivity Reactions

Inform patients that local hypersensitivity and skin reactions, including urticaria and dermatitis, have been reported in patients treated with FILSUVEZ. …

Warnings & precautions

Do not take this medicine if: None.

Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis.

If signs and symptoms of local or systemic hypersensitivity occur, discontinue FILSUVEZ immediately and initiate appropriate therapy.

Birch Triterpenes side effects

The following clinically significant adverse reactions are discussed elsewhere in the labeling:

Hypersensitivity Reactions

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The safety of FILSUVEZ was evaluated in EASE, a randomized, double-blind, multicenter, placebo-controlled trial in 223 adult and pediatric subjects with inherited EB. During the double-blind phase of EASE, subjects received topical treatment with either FILSUVEZ or a placebo gel on partial-thickness wounds every 1 to 4 days for a total of 90 days. Treated wounds were covered with non-adhesive dressings. Following completion of the double-blind phase, all subjects received FILSUVEZ for a total of 24 months during the open-label phase .

Table 1 presents adverse reactions that occurred in at least 2% of subjects treated with FILSUVEZ during the 90-day double-blind phase of EASE and at a greater frequency than in the placebo gel group.

Adverse Reaction | FILSUVEZ(N=109)n (%) | Placebo Gel(N=114)n (%)

Application site reactionIncludes: application site pruritus, administration site pain, administration site pruritus. | 8 (7.3) | 7 (6.1)

Squamous cell carcinoma of the skin (SCC) was reported as an adverse event in the double-blind and open-label periods of EASE. …

About this medicine

FILSUVEZ (birch triterpenes) topical gel is a sterile botanical drug product for topical use and contains birch triterpenes in an oil base. FILSUVEZ is a colorless to slightly yellowish, opalescent, non-aqueous gel.

Birch triterpenes is a botanical drug substance composed of a mixture of pentacyclic triterpenes. The botanical drug substance is a dry extract, refined, from birch bark from Betula pendula Roth, Betula pubescens Ehrh., as well as hybrids of both species, quantified to 72-88% (w/w) betulin, 2.4-5.7% (w/w) lupeol, 2.6-4.2% (w/w) betulinic acid, 0.5-1.2% (w/w) erythrodiol, 0.3-0.8% (w/w) oleanolic acid.

The structural formulae of the main triterpene constituents are shown in Figure 1.

Figure 1: Structure of Triterpene Constituents

Betulin | Erythrodiol

Betulinic acid | Oleanolic acid

Lupeol

Each gram of FILSUVEZ topical gel 10% (w/w) contains 100 mg of birch triterpenes in an oil base of refined sunflower oil. FILSUVEZ contains no additional excipients. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 32ba9194-734c-47d4-84e1-b21e28a85ec5. Read the full official label on DailyMed.